Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2654 |
|
| Actual shortage: | 249 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2396 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
329 (11%) |
|
Overdue reports |
26 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Resolved | 2023-06-19 | 2023-07-14 | 195501 |
| TEVA-LISINOPRIL/HCTZ (TYPE Z) | 12.5MG 20MG | TABLET | Resolved | 2023-06-19 | 2023-07-14 | 195597 |
| TEVA-NAPROXEN EC | 500MG | TABLET (ENTERIC-COATED) | Resolved | 2023-07-04 | 2023-07-14 | 197052 |
| ACT ENALAPRIL | 2MG | TABLET | Resolved | 2023-04-27 | 2023-07-14 | 190776 |
| TEVA-SIMVASTATIN | 40MG | TABLET | Resolved | 2023-01-12 | 2023-07-12 | 180912 |
| TEVA-PROPRANOLOL | 10MG | TABLET | Resolved | 2023-02-09 | 2023-07-12 | 184177 |
| TEVA-PROPRANOLOL | 40MG | TABLET | Resolved | 2023-02-09 | 2023-07-12 | 184180 |
| TEVA-TELMISARTAN | 80MG | TABLET | Resolved | 2023-04-27 | 2023-07-12 | 190749 |
| TEVA-QUETIAPINE XR | 150MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-06-08 | 2023-07-12 | 194163 |
| TEVA-SPIRONOLACTONE | 100MG | TABLET | Resolved | 2023-06-16 | 2023-07-12 | 195225 |
| TEVA-PINDOLOL | 15MG | TABLET | Resolved | 2023-06-19 | 2023-07-12 | 195533 |
| TEVA-TELMISARTAN | 80MG | TABLET | Resolved | 2023-06-19 | 2023-07-12 | 195603 |
| TEVA-OXYCOCET | 325MG 5MG | TABLET | Resolved | 2023-06-20 | 2023-07-12 | 195839 |
| TEVA-FUROSEMIDE | 20MG | TABLET | Resolved | 2022-10-17 | 2023-07-12 | 172018 |
| TEVA-FUROSEMIDE | 20MG | TABLET | Resolved | 2023-06-19 | 2023-07-12 | 195459 |
| TEVA-AZATHIOPRINE | 50MG | TABLET | Resolved | 2023-06-19 | 2023-07-12 | 195606 |
| ACT ENALAPRIL | 16MG | TABLET | Resolved | 2023-02-02 | 2023-07-12 | 183395 |
| ACT QUETIAPINE | 25MG | TABLET | Resolved | 2023-06-26 | 2023-07-12 | 196367 |
| ACT MEMANTINE | 10MG | TABLET | Resolved | 2023-06-16 | 2023-07-07 | 195180 |
| TEVA-TRAZODONE | 50MG | TABLET | Resolved | 2022-05-12 | 2023-07-06 | 160457 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-FUROSEMIDE | 20MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14039 |
| LEUCOVORIN CALCIUM INJECTION | 10MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14036 |
| GEMCITABINE FOR INJECTION | 1G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14033 |
| ZOLEDRONIC ACID INJECTION | 5MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14030 |
| EPTIFIBATIDE INJECTION | 2MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14027 |
| EPTIFIBATIDE INJECTION | 0.75MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14024 |
| CLOXACILLIN SODIUM FOR INJECTION | 2G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14021 |
| CLOXACILLIN SODIUM FOR INJECTION | 1G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14018 |
| CLOXACILLIN SODIUM FOR INJECTION | 500MG | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14014 |
| TEVA-PRAMIPEXOLE | 1.5MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14007 |